Feldstein AE - Search Results

1

Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future.

Wieckowska A, McCullough AJ, Feldstein AE. Wieckowska A, et al. Among authors: feldstein ae. Hepatology. 2007 Aug;46(2):582-9. doi: 10.1002/hep.21768. Hepatology. 2007. PMID: 17661414 Review.

2

Nonalcoholic fatty liver disease in the pediatric population: a review.

Wieckowska A, Feldstein AE. Wieckowska A, et al. Among authors: feldstein ae. Curr Opin Pediatr. 2005 Oct;17(5):636-41. doi: 10.1097/01.mop.0000172816.79637.c5. Curr Opin Pediatr. 2005. PMID: 16160540 Review.

3

In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease.

Wieckowska A, Zein NN, Yerian LM, Lopez AR, McCullough AJ, Feldstein AE. Wieckowska A, et al. Among authors: feldstein ae. Hepatology. 2006 Jul;44(1):27-33. doi: 10.1002/hep.21223. Hepatology. 2006. PMID: 16799979

4

Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis.

Wieckowska A, Papouchado BG, Li Z, Lopez R, Zein NN, Feldstein AE. Wieckowska A, et al. Among authors: feldstein ae. Am J Gastroenterol. 2008 Jun;103(6):1372-9. doi: 10.1111/j.1572-0241.2007.01774.x. Epub 2008 May 28. Am J Gastroenterol. 2008. PMID: 18510618

5

Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive.

Wieckowska A, Feldstein AE. Wieckowska A, et al. Among authors: feldstein ae. Semin Liver Dis. 2008 Nov;28(4):386-95. doi: 10.1055/s-0028-1091983. Epub 2008 Oct 27. Semin Liver Dis. 2008. PMID: 18956295 Review.

6

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study.

Feldstein AE, Wieckowska A, Lopez AR, Liu YC, Zein NN, McCullough AJ. Feldstein AE, et al. Hepatology. 2009 Oct;50(4):1072-8. doi: 10.1002/hep.23050. Hepatology. 2009. PMID: 19585618 Free PMC article.

7

Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study.

Carter-Kent C, Yerian LM, Brunt EM, Angulo P, Kohli R, Ling SC, Xanthakos SA, Whitington PF, Charatcharoenwitthaya P, Yap J, Lopez R, McCullough AJ, Feldstein AE. Carter-Kent C, et al. Among authors: feldstein ae. Hepatology. 2009 Oct;50(4):1113-20. doi: 10.1002/hep.23133. Hepatology. 2009. PMID: 19637190 Free PMC article.

8

Pentoxifylline improves nonalcoholic steatohepatitis: a randomized placebo-controlled trial.

Zein CO, Yerian LM, Gogate P, Lopez R, Kirwan JP, Feldstein AE, McCullough AJ. Zein CO, et al. Among authors: feldstein ae. Hepatology. 2011 Nov;54(5):1610-9. doi: 10.1002/hep.24544. Epub 2011 Aug 24. Hepatology. 2011. PMID: 21748765 Free PMC article. Clinical Trial.

9

Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: new evidence on the potential therapeutic mechanism.

Zein CO, Lopez R, Fu X, Kirwan JP, Yerian LM, McCullough AJ, Hazen SL, Feldstein AE. Zein CO, et al. Among authors: feldstein ae. Hepatology. 2012 Oct;56(4):1291-9. doi: 10.1002/hep.25778. Hepatology. 2012. PMID: 22505276 Free PMC article. Clinical Trial.

10

Relations of steatosis type, grade, and zonality to histological features in pediatric nonalcoholic fatty liver disease.

Carter-Kent C, Brunt EM, Yerian LM, Alkhouri N, Angulo P, Kohli R, Ling SC, Xanthakos SA, Whitington PF, Charatcharoenwitthaya P, Yap J, Lopez R, McCullough AJ, Feldstein AE. Carter-Kent C, et al. Among authors: feldstein ae. J Pediatr Gastroenterol Nutr. 2011 Feb;52(2):190-7. doi: 10.1097/MPG.0b013e3181fb47d3. J Pediatr Gastroenterol Nutr. 2011. PMID: 21240012

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

225 results

Search Page

Filters